BRGX (BioRegenx) Issuance of Debt : $0.52 Mil (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is BioRegenx Issuance of Debt?

BioRegenx's Issuance of Debt for the three months ended in Dec. 2024 was $0.00 Mil.

BioRegenx's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was $0.52 Mil.

BioRegenx Issuance of Debt Historical Data

The historical data trend for BioRegenx's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Issuance of Debt Chart

BioRegenx Annual Data

Trend

Dec00

Dec01

Dec02

Dec03

Dec04

Dec20

Dec21

Dec22

Dec23

Dec24

Issuance of Debt

Get a 7-Day Free Trial

0.15

0.05

0.04

0.09

0.49

BioRegenx Quarterly Data
	Mar05	Jun05	Sep05	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Issuance of Debt	Get a 7-Day Free Trial															-	0.30	0.13	0.09	-

BioRegenx Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.52 Mil.

BioRegenx Issuance of Debt Related Terms

Thank you for viewing the detailed overview of BioRegenx's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRegenx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

7407 Ziegler Road, Chattanooga, TN, USA, 37421

Website

https://www.bioregenx.com

BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.